Fig. 3 (IMAGE)

Osaka University

Fig. 3

Caption

Antitumor effects after REST_SSO administration in xenograft mice bearing tumors, originating from the PCa cells. a, Relative tumor volume. b, AST/ALT test using blood samples obtained on day 9. c, Body weight. d, Images of tumors obtained in different groups. e, REST_SSO levels in the tumor, livers, and kidneys were analyzed.

Credit

2024 Shimojo et al., Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer, Molecular Therapy Nucleic Acids

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.